Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial

Urology ◽  
2001 ◽  
Vol 58 (6) ◽  
pp. 953-959 ◽  
Author(s):  
Claus G Roehrborn
Sign in / Sign up

Export Citation Format

Share Document